Suzanne George Selected Research

Leiomyosarcoma

1/2022	Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma.
1/2021	Leiomyosarcoma: Does Location of Primary Help to Determine the Best Systemic Therapy Options?
1/2020	A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas.
1/2019	Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease.
1/2019	Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy".
1/2018	SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy.
9/2017	Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.
1/2017	Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.
1/2016	Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery.
10/2014	Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzanne George Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 11/2003
35	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 12/2002
24	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 05/2007
15	Leiomyosarcoma 01/2022 - 04/2013
13	Disease Progression 11/2021 - 09/2007
6	Hypertension (High Blood Pressure) 01/2020 - 12/2007
5	Fatigue 10/2020 - 10/2006
4	Aggressive Fibromatosis (Desmoid) 12/2020 - 08/2012
3	Nausea 10/2020 - 10/2006
3	Diarrhea 10/2020 - 01/2011
3	Leiomyoma (Uterine Fibroids) 01/2016 - 05/2013
3	Stomatitis 06/2014 - 10/2011
3	Breast Neoplasms (Breast Cancer) 11/2012 - 11/2003
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2011 - 11/2006
2	Anemia 11/2021 - 11/2014
2	Alveolar Soft Part Sarcoma 01/2019 - 07/2015
2	Ewing Sarcoma (Sarcoma, Ewing) 10/2017 - 11/2014
1	Pulmonary Embolism 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Abdominal Pain (Pain, Abdominal) 11/2021
1	Myalgia 10/2020
1	Alopecia (Baldness) 10/2020
1	Constipation 10/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Dehydration (Water Stress) 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Synovial Sarcoma (Synovioma) 01/2020
1	Liposarcoma 01/2020
1	Myxoid Liposarcoma 01/2020
1	Smooth Muscle Tumor 01/2019
1	Turcot syndrome 01/2019
1	Rare Diseases (Rare Disease) 10/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Endometrial Stromal Sarcoma 01/2017
1	Spontaneous Remission 05/2016
1	Fibroma (Fibromatosis) 05/2016
1	Genetic Translocation (Chromosomal Translocation) 07/2015

Drug/Important Bio-Agent (IBA)

19	Imatinib Mesylate (Gleevec)FDA Link 10/2020 - 09/2007
14	Sunitinib (Sutent)FDA Link 01/2020 - 11/2006
12	Tyrosine Kinase InhibitorsIBA 12/2021 - 12/2002
11	Phosphotransferases (Kinase)IBA 03/2021 - 05/2006
10	Pharmaceutical PreparationsIBA 01/2021 - 05/2007
7	ripretinibIBA 12/2021 - 01/2020
7	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021 - 01/2011
5	regorafenibIBA 10/2021 - 07/2012
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2012
4	avapritinibIBA 10/2021 - 10/2020
4	Biological ProductsIBA 01/2020 - 07/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 04/2015
3	Circulating Tumor DNAIBA 01/2022 - 01/2019
3	Tyrosine (L-Tyrosine)FDA Link 03/2021 - 12/2015
3	Gemcitabine FDA Link 01/2019 - 05/2007
3	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 02/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2013
3	Everolimus FDA Link 04/2013 - 02/2011
2	tyrosine receptor (receptor, tyrosine)IBA 01/2021 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 01/2019
2	mocetinostatIBA 01/2019 - 01/2018
2	pembrolizumabIBA 01/2019 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2017
2	olaratumabIBA 01/2019 - 01/2017
2	Histone Deacetylase InhibitorsIBA 01/2018 - 04/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2015 - 09/2008
2	ridaforolimusIBA 04/2013 - 10/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2007 - 05/2006
1	ponatinibIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	Immunoglobulin IsotypesIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 10/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2020
1	PM 01183IBA 01/2020
1	pazopanib FDA Link 01/2019
1	larotrectinibIBA 01/2019
1	NucleotidesIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Cyclin D1IBA 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 10/2017
1	Ifosfamide FDA LinkGeneric 10/2017
1	Etoposide (VP 16)FDA LinkGeneric 10/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2017
1	NivolumabIBA 09/2017
1	LigandsIBA 09/2017
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 07/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	Monoclonal AntibodiesIBA 12/2015
1	Bevacizumab (Avastin)FDA Link 12/2015
1	SuspensionsIBA 07/2015
1	VaccinesIBA 07/2015

Therapy/Procedure

33	Therapeutics 01/2022 - 05/2006
7	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
7	Radiotherapy 12/2020 - 09/2009
4	Immunotherapy 01/2019 - 01/2017
3	Morcellation 01/2016 - 10/2014
2	Drug Tapering 04/2013 - 10/2011
1	Duration of Therapy 11/2021
1	Neoadjuvant Therapy 01/2018
1	Operative Surgical Procedures 01/2017
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2016